Comparatively, low expression of FAM83B was linked to a poorer prognosis for CHOL and READ, while high expression of FAM83B resulted in worse survival for PAAD (p = 0.016, Figure 3B) and MESO (Supplementary Table S2). This evidence concerns the gene SACK1B and pancreatic adenocarcinoma.